Back to search results

Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy

Abroad (travel likely)RecruitingPHASE2

Conditions

Diffuse Large B Cell Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Moffitt Cancer Center, Tampa, Florida, United States

    Contact: Study coordinator (Kelsey Lee) · ICETtrials@moffitt.org · 813-745-8228
    Contact: Principal Investigator (Michael Jain, MD, PhD)
    Julio Chavez, MD, MS (Sub-investigator)
    Rawan Faramand, MD (Sub-investigator)
    Farhad Khimani, MD (Sub-investigator)
    Aleksandr Lazaryan, MD, MPH, PhD (Sub-investigator)
    Hien Liu, MD (Sub-investigator)
    Frederick Locke, MD (Sub-investigator)
    Taiga Nishihori, MD (Sub-investigator)
    Javier Pinilla, MD, PhD (Sub-investigator)
    Bijal Shah, MD, MS (Sub-investigator)
Study leads

  • Michael Jain, MD, PhD

    Principal Investigator

    Moffitt Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)